DERMHAGE Fine Touch (1 x 1ml)

DERMHAGE products provide safe and long-lasting results for patients while utilising groundbreaking and patented Smooth Rheology Hyaluronic Acid (SRHA) technology. SHRA technology preserves the natural qualities of pure HA and combined with a premium syringe improves safety and control for practitioners, guaranteeing a smooth, precise and homogeneous application.
There are four products in the range with varying molecular weights, allowing practitioners to offer a bespoke treatment plan for patients of all genders, ages, skin types and with a range of concerns:

20mg/ml HA concentration 
For soft tissue correction and fine lines including crows’ feet, tear troughs, acne scarring, stretch marks, and smokers’ lines. 
Depth of injection: between dermal and epidermal layers, superficial to supraperiostal. 
Injection techniques: papula or micro-papula, threading, blanching. 
Effect duration: 6 to 9 months 
Clinical trials have proven DERMHAGE fillers best resemble Juvederm and Restylane
DERMHAGE fillers are available at a more commercial price

Key Features:

Patented SHRA technology 
Lab tested and found to resemble Juvederm and Restylane 
Class III Medical Device with CE Mark 0483 and ISO 13485 
Designed and made in the EU using pure French HA 
Low extrusion force 
Premium syringe for better safety, control and comfort 
Extra precision with visual graduation 
1 x 1ml per unit 
Includes 2 x thin 27G x ½” Terumo needles 
36-month shelf life 
Immediately visible results with excellent product projection

Dermhage Must Not Be Used In: 

People under the age of 18
Women who are pregnant or breastfeeding
Patients who are known to have a sensitivity to hyaluronic acid
Immediately before or post chemical peeling, laser therapy or dermabrasion
Areas presenting signs of infection or cutaneous inflammation
Patients who tend to develop hypertrophic scarring